INO stock: buy or sell

INO stock price: $8.67 4.96% At close on Jul 28th, 2021

Updated on:
Jul 29th, 2021

1

INO stock brief

  • Inovio Pharmaceuticals stock skyrocketed 4.96% to close at $8.67 on the stock market on Wednesday.
  • Looking at the chart, price is drawing an scaled downtrend since last February with lower tops and lower bottoms. shares price lost a -54.37% since the downtrend started.

Should I buy Inovio Pharmaceuticals stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $INO stock a buy?

Currently, Inovio Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean $INO will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Inovio Pharmaceuticals stock?

"To sell or not to sell", if you are holding Inovio Pharmaceuticals stock?. In the same way as when we have to buy shares, choosing when is appropiate time to sell is not a whimsical decision, and we must use our own trading style. When selling, as well as buying, detailed strategies are very easy to use and are only valid for selling shares you already own, not for selling short $INO stock

As a golden rule, you should never mantain an open trade that generates higher than expected losses upon the buy. When to sell your stock always has to be ruled by the stop-loss (automatic or manual)

Is it time to sell Inovio Pharmaceuticals stock?

In the current situation of Inovio Pharmaceuticals there is not any eligible sell setup, so Inovio Pharmaceuticals stock holders with operations in green can keep their positions

Inovio Pharmaceuticals ratings

We don't have any rating posted in the last 30 days for Inovio Pharmaceuticals

Inovio Pharmaceuticals stock analysis

Inovio Pharmaceuticals accumulates a selloff of -54.37% since its latest top last February at $19.00. The stock drew 4 consecutive lower tops.

SMAs overview

INO stock SMAs chart

Supports and resistances

The current resistance levels are:

  • R1: $8.78 (1.27% above)
  • R2: $8.80 (1.50% above)
  • R3: $8.83 (1.85% above)
  • The current support levels are:

  • S1: $8.63 (-0.46% below)
  • S2: $8.62 (-0.58% below)
  • S3: $8.60 (-0.81% below)
  • Bollinger bands

    INO stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 in mid-June after just crossing to the overbough zone for a single day (weak signal). The RSI reading on Wednesday was 53.15. Since RSI lost the overbought zone, Inovio Pharmaceuticals shares tanked a 13.56%

    INO stock RSI chart

    Inovio Pharmaceuticals stock price history

    Inovio Pharmaceuticals went public on Dec 8th, 1998 priced at $60.00 per share1. Since then, INO stock declined by -85.55%. An investment of thousand dollars on the IPO would have a value of $144.50 nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    INO stock price history chart

    Price target for Inovio Pharmaceuticals stock

    Nobody knows how much a share will be priced tomorrow. Banks and financial organisations publish their analysis forecasting how a stock will performance in the future.

    The following table shows the price predictions published by financial institutions over the last 30 days. Again, these targets are not direct recommendations for small investors and must not be trusted blindly.

    We don't have any target price posted in the previous month for Inovio Pharmaceuticals.

    Earnings and financials

    Inovio Pharmaceuticals ($INO) had the shareholders call and released the report last May. INO presented earnings of $-0.27 per share versus analysts estimate that was $-0.18.

    In comparison, the EPS for the same quarter last year was $-0.26, so reported EPS means a loss of -3.85%. Looking at turnover, figures collapsed a -72.04% compared to $13.3M year over year.

    INO ($INO) is releasing earnings report next Monday. Market analysts analysts forecast of $-0.25, that is a 7.41% more than Q1.

    Inovio Pharmaceuticals performance

    INO performance compared
    Company1m3m6m
    Inovio Pharmaceuticals ($INO) -8.50% 22.60% -30.80%

    Please read:
    The viewpoints published in this post are personal and not recommendations for you to buy or sell stocks. The author of this article does not have an understanding of the individual situations of the reader, his or her own financial statements or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are provided for educative motives only

    INO summary

    Wednesday, July 28th, 2021
    Open$8.34
    Close$8.67
    Day range$8.27 - $8.74
    Previous close$8.26
    Session gain4.96%
    Average true range$0.52
    50d mov avg$8.35
    100d mov avg$8.40
    200d mov avg$9.80
    Earnings dateAugust 9th, 2021

    Frequently asked questions

    What is Inovio Pharmaceuticals stock symbol?

    Inovio Pharmaceuticals, Inc. is a public company trading in the US stock market with the INO symbol

    Is Inovio Pharmaceuticals stock a buy or sell?

    Inovio Pharmaceuticals had no ratings in the last 30 days Read the article to get additional tips on trading INO stock.

    Will INO go up?

    There were no forecasts published by market analysts in the last month for Inovio Pharmaceuticals.